Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension

被引：0
|
作者：
Funasako, Moritoshi [1 ]
Miyaji, Katsumasa [1 ]
Sakuma, Masahito [1 ]
Takagi, Yaemi [1 ]
Kyotani, Shingo [1 ]
Nakanishi, Norifumi [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Cntr, Suita, Osaka, Japan
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Pulmonary hypertension; Thyroid hormones;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A19627
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension
    Rich, Stuart
    Pogoriler, Jennifer
    Husain, Aliya N.
    Toth, Peter T.
    Gomberg-Maitland, Mardi
    Archer, Stephen L.
    CHEST, 2010, 138 (05) : 1234 - 1239
  • [2] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [3] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension
    Kim, NH
    Channick, RN
    Rubin, LJ
    CHEST, 2003, 124 (04) : 1612 - 1615
  • [5] Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy
    Myers, SA
    Ahearn, GS
    Selim, MA
    Tapson, VE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (01) : 98 - 102
  • [6] Epoprostenol infusion therapy changes angiographic findings of pulmonary arteries in patients with idiopathic pulmonary arterial hypertension
    Sakuma, Masahito
    Demachi, Jun
    Nawata, Jun
    Suzuki, Jun
    Takahashi, Tohru
    Matsubara, Hiromi
    Akagi, Satoshi
    Shirato, Kunio
    CIRCULATION JOURNAL, 2008, 72 (07) : 1147 - 1151
  • [7] Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension
    Simonneau, Gerald
    Rubin, Lewis J.
    Galie, Nazzareno
    Barst, Robyn J.
    Fleming, Thomas R.
    Frost, Adaani
    Engel, Peter
    Kramer, Mordechai R.
    Serdarevic-Pehar, Marjana
    Layton, Gary R.
    Sitbon, Olivier
    Badesch, David B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (07): : 689 - 697
  • [8] Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
    Simonneau, Gerald
    Rubin, Lewis J.
    Galie, Nazzareno
    Barst, Robyn J.
    Fleming, Thomas R.
    Frost, Adaani E.
    Engel, Peter J.
    Kramer, Mordechai R.
    Burgess, Gary
    Collings, Lorraine
    Cossons, Nandini
    Sitbon, Olivier
    Badesch, David B.
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (08) : 521 - W102
  • [9] Long-Term Oral Sildenafil Added to Intravenous Epoprostenol Therapy Improves Outcomes in Patients With Pulmonary Arterial Hypertension
    Simonneau, G.
    Rubin, L. J.
    Galie, N.
    Fleming, T. R.
    Gillies, H.
    Barst, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [10] Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
    Delcroix, Marion
    Simonneau, Gerald
    Bergot, Emmanuel
    Boonstra, Anco
    Granton, John
    Langleben, David
    Subias, Pilar Escribano
    Galie, Nazzareno
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345